Vanberra Signal

Breathomix

Curated by Signal

Provider of the device and AI enabled platform for respiratory health diagnosis

Overview

Provider of the device and AI-enabled platform for respiratory health diagnosis. The device is used by medical professionals for eNose examination where the exhaled breath is analyzed and stored in an online database. The Breathbase platform uses AI to provide real-time point-of-care breath analysis and diagnostic results based on the individual phenotype and biomarkers.

Key facts

Founded
2018

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of a bioinformatics computational platform for the analysis of biological data

    Life Sciences TechnologyNijmegen, Netherlands
  • Provider of an AI-powered automated liquid handling platform

    Life Sciences TechnologyAmsterdam, Netherlands
  • AI based diagnostic tools for tumours

    Life Sciences TechnologyAmsterdam, Netherlands

About Breathomix

What does Breathomix do?

Provider of the device and AI-enabled platform for respiratory health diagnosis.

Where is Breathomix headquartered?

Breathomix is headquartered in Leiden, Netherlands.

When was Breathomix founded?

Breathomix was founded in 2018.

Which sector is Breathomix in?

Breathomix operates in Life Sciences Technology.

Who are Breathomix's competitors?

Companies similar to Breathomix include Bio-Prodict, Digi.Bio, and WSK Medical.